Boston Scientific apologizes for embargo breach that got its Watchman trial pulled from conference

March 10, 2013 by Arezu Sarvestani

American College of Cardiology conference organizers cancel the highly anticipated presentation of preliminary results from Boston Scientific's PREVAIL study after the company accidentally leaks the data ahead of time. Boston Scientific publishes the slides that would have been presented at this weekend's American College of Cardiology meeting had the company preserved the embargo on the findings.

Updated March 9, 2013, at 8:30 p.m. PST with comment, slides from Boston Scientific.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.